ABVC Slashes Land-Acquisition Share Cap to 1.6M, Discloses Board Member as Seller
ABVC sits 43% above its 52-week low of $0.707.
Summary
ABVC's revised proxy cuts the land-acquisition share cap to 1.6M shares and reveals the seller is a Board member holding ~14% of voting power. Appraisals value the Taiwan properties at ~US$622K, payable entirely in stock.
Key Events · Corporate Governance and Compliance · ABVC
-
Land-Acquisition Share Cap Cut to 1.6M
Maximum issuance for the Taiwan land acquisition reduced from 6.6 million shares to 1,600,653 shares at no less than $1.00 per share.
-
Board Member Identified as Seller
Ms. Shuling Jiang, a Board member, is the seller and currently owns 3,735,572 shares (~14% voting power). Full issuance would raise her stake to ~18.86%.
-
Appraisals Value Properties at ~US$622K
Independent appraisals value Taoyuan Lands at NT$10,948,541 (~US$339,048) and Hualien Property at NT$9,146,467 (~US$283,243), totaling NT$20,095,008 (~US$622,291).
-
2026 Equity Incentive Plan Details
Award pool set at 1,169,201 shares plus 15% of outstanding on meeting date, with a 5% annual evergreen provision starting 2027.
Analysis · ABVC · Life Sciences
The third proxy amendment from ABVC materially revises the proposed land acquisition: the maximum share issuance drops from 6.6 million to 1,600,653 shares, and the seller is now identified as Board member Shuling Jiang, who already holds ~14% of voting power. Independent appraisals value the Taiwan properties at ~US$622,291, with consideration to be paid entirely in stock at no less than $1.00 per share. Given the related-party nature of the deal and the potential for the seller's ownership to rise to ~18.86%, this is a governance-sensitive transaction that shareholders should scrutinize before the October 8 vote.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.2% of the 1943 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ABVC was trading at $1.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.5M. The 52-week trading range was $0.71 to $3.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.